Find your tools for building human cell-based models & screening assays
Featured Product
Microglia
Human iPSC-derived Microglia provide a reliable and consistent model that phenotypically recapitulates human microglia responses in vitro.
Featured Service
Cell Reprogramming
A complete suite of custom cell reprogramming and characterization services from dedicated specialists to generate iPSCs from human cells using cutting edge technologies.
Featured White Paper
Atrial Cardiomyocytes
Are you using non-human cell models for your cardiac research? Download our new white paper to find out why human iPSC-derived Atrial Cardiomyocytes could improve your data.
Welcome to Axol Bioscience
YOUR HUMAN CELL CULTURE SPECIALISTS
We provide highly validated human iPSC-derived cells and primary cells from healthy donors and patients of specific disease backgrounds, together with optimized media and growth supplements. Axol aims to develop the best human cell biology research tools to advance medical research and drug discovery. Combining our passion for science with quality, innovation and customer service, we deliver robust and reliable products that our customers need to advance their research faster.
Introduction of MEA screening services for human iPSC-derived cells
13 October 2020
Axol Bioscience today announced the expansion
of its service offering, with the introduction of multi-electrode array (MEA)
screening for human induced pluripotent stem cell (hiPSC)-derived cells. The
new services have been developed to support pre-clinical research by optimizing
hiPSC-derived cell culture, while providing high-quality electrophysiological
data acquisition and analysis from physiologically relevant human cell models.
Axol Bioscience appoints Liam Taylor as Chief Executive Officer
27 August 2020
Cambridge, UK, 26 August 2020: Axol Bioscience, a biotechnology company specializing in the use of stem cell technology to manufacture disease relevant cell based assay systems to the drug discovery industry, today announced the appointment of Liam Taylor as CEO. Liam will guide the growth of the Company, and will focus on maximizing the potential of the team, and its iPSC (induced pluripotent stem cell) technologies, products and services.
Major success for MESO-BRAIN partners will lead to breakthrough technology for developing new brain models
Axol Bioscience launch human iPSC-derived Microglia
13 December 2018
Cambridge, UK – (6th December 2018) – Axol Bioscience, the human cell culture specialist, is launching a new line of Human induced Pluripotent Stem Cells (iPSC)-derived Microglia for the consistent and reproducible study of neuroglia and their involvement in neurodegenerative diseases, including Alzheimer’s disease, multiple sclerosis and Parkinson’s disease.
How to Order
To place an order or request a quotation simply add the desired products to your shopping cart and then click "Process Checkout" to provide the billing and shipping information. On the payment page you can then either pay immediately or download a quotation.
Order Confirmed
Thank you for your order. We have received your purchase order successfully and will start processing it as soon as possible.
We will be in touch shortly.
Issue with Order Detected
There was an issue with your submitted order as follows: Unidentified Error Please resolve this issue and try again. If you are unable to do so, please contact us via the contact form and we'll do our best to resolve your issue.
